FPH - Fisher Paykel Healthcare.

[kiora]

For those investors that are worrying about weight loss drugs impacting sales.
With all the news about them it has lead to an increase in health consultations.These lead to health programmes that also include treatment for obstructive sleep apnea.
The overall affect for FPH sleep apnea products:Positive


https://www.pewresearch.org/science/...ty-in-the-u-s/

[kiora]

"So what we're hearing back from the sleep practitioners, and the weight loss practitioners, is that CPAP - which is the treatment that ResMed put forward to sleep apnea - is still the primary solution for sleep apnea. The other thing we're observing is that GLP-1s, if anything, are just increasing the treatment awareness for sleep apnea. "
https://www.livewiremarkets.com/wire...AD%20%20LISTEN

[Panda-NZ-]

Wieight loss drugs found to reduce dementia risk by half alongside treating addiction.

https://www.investors.com/news/techn...dementia-risk/

They do seem to be cure-alls even without those bonuses (weight is a major contributing factor to many diseases, aside from age). I think they are charging far less than they "could" for these drugs. Happy investor in eli lilly rather than restricting myself to NZ companies.